A recent study showed that bioactive natural gallic acid inhibited PD-L1/PD-1 interaction by regulating epidermal growth factor receptor (EGFR)/p53 signaling in NSCLC cells [26]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.